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Abstract 
 
A decade ago, the (pro)renin receptor ((P)RR) was discovered and depicted as a 
potential activator of the tissue renin-angiotensin system. For this reason, the role of the 
(P)RR in cardiovascular diseases and diabetes has been particularly studied. However, 
the discovery of embryonic lethality after (P)RR gene deletion in mouse and zebrafish 
paved the way for additional roles of (P)RR in cell homeostasis. Indeed, the (P)RR has 
been shown to associate with the vacuolar H+-ATPase, hence its other name ATP6ap2. 
Developmental studies in Xenopus and Drosophila have revealed an essential role of this 
association to promote the canonical and non-canonical Wnt signaling pathways, while 
studies with tissue specific gene deletion have pointed out a role in autophagy. This 
review aims to summarize recent findings on the cellular functions of (P)RR emerging 
from various mutated and transgenic animal models. 
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Abbreviations: Ang I, angiotensin I; Ang II, angiotensin II; ER, endoplasmic reticulum; Fmi, 
Flamingo; Fz, Frizzled; HRP, handle region peptide; KO, knockout; LRP6, low-density lipoprotein 
receptor-related protein 6; MAPK, mitogen-activated protein kinase; MVBs, multivesicular bodies; 
PCP, planar cell polarity; pn, pekin; (pro)renin, prorenin and renin; (P)RR, (pro)renin receptor; RAS, 
renin-angiotensin system; RNAi, RNA interference; siRNA, small interfering RNA; s(P)RR, soluble 
(P)RR; V-ATPase, vacuolar H+-ATPase; XLMR, X-linked mental retardation; XPDS, X-linked 
Parkinsonism with spasticity. 
INTRODUCTION 
 
For many years, the renin-angiotensin system (RAS) has been described as a circulating 
system essential for the regulation of blood pressure and salt homeostasis. Within the 
enzymatic cascade leading to angiotensin II (AngII) generation, renin controls the rate-
limiting conversion of circulating angiotensinogen into angiotensin I (AngI). The common 
view was that renin was biologically active only after its proteolytic activation in 
juxtaglomerular cells of the kidney and its secretion into the blood circulation. Its precursor 
prorenin was believed to have no functional relevance. The emergence of a tissue RAS with 
the local production of AngII and the discovery of several new components have challenged 
these dogma [1]. In 2002, Nguyen et al. provided confirmatory evidence for concept with the 
discovery of a membrane-bound protein that could bind both prorenin and renin ((pro)renin) 
[2] (Figure 1). The protein was called (pro)renin receptor ((P)RR) and differed from other 
described (pro)renin binding sites by its ability, upon (pro)renin binding, to trigger cellular 
responses. 
Upon binding to (P)RR, first, the enzymatic activity of prorenin and renin was enhanced, 
resulting in increased AngI production and the subsequent generation of AngII at the tissue 
level. In addition, activation of (P)RR triggered intracellular activation of several Mitogen-
activated protein kinases (MAPK) and led to the secretion of inflammatory and pro-fibrotic 
molecules in various cell types ([2]. As these latter signaling events occurred independently of 
the generation of AngII, it was suggested that (pro)renin-bound (P)RR might promote direct 
tissue damage and contribute to the pathogenesis of cardiovascular diseases by assisting in the 
activation of the local RAS. Thus, (P)RR directly became an interesting target to decrease 
end-organ damage associated with hypertension and diabetes and to complement the arsenal 
of anti-hypertensive drugs, which do not fully prevent these tissue damages. 
In 2004, a (P)RR blocker susceptible to interfere with prorenin/(P)RR interaction, was shown 
to decrease renal AngII levels and to prevent the development of nephropathy in diabetic rats 
[3]. Despite these encouraging results, conflicting data were obtained in various animal 
models and raised a controversy about the binding ability, specificity and properties of this 
blocker. These aspects have been extensively reviewed and will not be further developed here 
[4-6]. 
The gene coding for the (P)RR is located on the X chromosome and codes for a protein with a 
length of 350 amino acids and an approximate mass of 37 kDa. Structural analysis of (P)RR 
has shown that it contains two hydrophobic domains predicted to be a signal peptide, and a 
transmembrane domain suggesting a type I transmembrane protein [7]. Thus, (P)RR can be 
divided into four domains: an N-terminal signal peptide, an extracellular domain binding 
(pro)renin, a single transmembrane domain and a short cytoplasmic domain (Figure 2) [8]. In 
addition, shedding by proteases such as furin or ADAM19 allows the generation of a long 
soluble fragment of 28-29 kDa composed of the (pro)renin binding domain (s(P)RR) and a 
short fragment composed of the transmembrane and intracellular domain ([9, 10]. The full-
length (P)RR seems to be ubiquitously expressed but in vivo data about the genesis and the 
regulation of soluble (P)RR are missing. 
Few years after (P)RR was discovered, and in parallel to its characterization as a receptor 
playing a role within the RAS, new evidence emerged, which would drastically change our 
vision on this protein and its function. In the paper by Nguyen et al. [2], (P)RR had been 
described to be partially identical to a protein identified as early as 1998 (Figure 1). In 
chromaffin cells of the adrenal medulla, Ludwig et al. [11] had described a truncated form 
(called M8-9) of the (P)RR roughly corresponding to the short fragment generated after 
shedding [12, 13]. This M8-9 portion was found to co-immunoprecipitate with the V-ATPase 
which would later urge the scientific community to rename (P)RR as V-ATPase-associated 
protein 2 (ATP6ap2). The V-ATPase is a multi-subunit complex composed of a peripheral V1 
domain (8 subunits) responsible of ATP hydrolysis and a V0 domain (6 subunits) responsible 
for proton translocation [14]. In addition, accessory subunits have been described, Ac45 
(ATP6ap1) and –hence– ATP6ap2, although this denomination has yet to be proven at the 
functional level. In most cells, V-ATPases are mainly located in intracellular compartments 
such as endosomes and lysosomes, among others. These proton pumps provide an acidic 
environment in the lumen of these vesicles essential for protein trafficking (endocytosis and 
exocytosis), maturation, recycling and degradation through pH-dependent enzymes [14, 15]. 
Also, in some specific cells, V-ATPases are targeted to the plasma membrane like in 
osteoclasts (to resorb bone) and in intercalated cells of the renal collecting duct (to acidify 
urine). Deletion or mutation of V-ATPase subunits in animal models and humans are 
associated to severe phenotypes including early death [16, 17].  
In light of the fact that (P)RR could be part of the V-ATPase complex, it has not been 
surprising that (P)RR was mainly found to be localized intracellularly, in contrast to its 
original description at the cell surface. Such intracellular localization has been since then 
substantiated by immunofluorescence and biochemical studies [7, 9, 10, 18-20]. In addition, 
sequence analysis has revealed two putative motifs in the cytoplasmic domain of (P)RR which 
further predict its targeting to distinct intracellular compartments [7, 12]. 
Thus, a few years after its discovery, as receptor for (pro)renin, it was suggested that (P)RR 
might play an additional role in association with the V-ATPase. But at that time, direct 
evidence was lacking and the research field was focused on the ability of (P)RR to stimulate 
the tissue RAS. Study with mutant zebrafish and the impossibility to generate (P)RR 
knockout (KO) mice suggested a more essential role of this protein than the RAS (Figure 1), 
thus engendering a progressive, yet irresistible, shift of the (P)RR research towards critical 
intracellular functions. However, additional years were necessary to conduct developmental 
studies and generate mice with tissue-specific deletion of (P)RR in order to unravel such 
functions. This review will summarize advances provided from various animal models and 
what is known in humans. 
ZEBRAFISH 
 
Studies with zebrafish provided early hints for a potential role of (P)RR as a V-ATPase 
accessory subunit. Indeed, zebrafish with insertional mutagenesis of (P)RR shared a common 
embryonic phenotype with mutants for several V-ATPase subunits (Figure 1). All mutants 
displayed abnormal pigmentation, multiple organ defects and necrosis in the central nervous 
system, finally resulting in lethality after 5 days of development [21, 22] (http://zfin.org). We 
obtained the same results using morpholino antisense oligonucleotide injections against 
(P)RR in zebrafish (Sihn et al., manuscript in preparation). These results suggested that (P)RR 
is important for embryonic development probably linked to V-ATPase activity but no direct 
evidence was provided by this animal model for years. Recently, Eauclaire et al. performed a 
chemical mutagenesis screen to identify proteins important for biliary development [23]. 
Among all mutants with abnormalities in hepatic development, one mutant called pekin (pn) 
was particularly studied. It turned out that the causative mutation in pn was located at the end 
of exon 8 of the atp6ap2 gene and led to a read-through and premature stop codon. 
Ultrastructural examination of bile duct cells revealed accumulation of electron dense bodies 
at the periphery of the cells. In addition, typical features of endoplasmic reticulum (ER) stress 
were also present. Thus, it was suggested that decreased ATP6ap2 levels altered protein 
trafficking and degradation probably by affecting V-ATPase function and altering vesicular 
pH. The presence of skin and eye hypopigmentation in pn provided further evidence as this 
phenotype was previously associated with inhibition of the V-ATPase [21, 22, 24, 25]. In the 
skin, melanoblast markers decreased with time which suggests that melanocytes developed 
normally but underwent degeneration [23]. In the eye, striking degradation of various cell 
layers was also observed. The fact that mutants for ATP6V0D1 and ATP6ap1 displayed 
defects in intrahepatic ducts similar to pn, and that renin morphant displayed minor defects 
suggested that ATP6ap2 is important for V-ATPase activity independently of its (pro)renin 
receptor ability. Further studies are necessary to reveal the exact mechanism for which (P)RR 
is essential in biliary development. 
 
 
XENOPUS 
 
In 2010, the group of C. Niehrs carried out a genome-wide siRNA screen in order to identify 
new members of the Wnt/β-catenin signaling pathway [26]. Wnts are a superfamily of 
secreted glycoproteins which signal through various receptors and co-receptors. The so-called 
canonical Wnt signaling involves β-catenin as a major downstream effector and is essential 
for embryonic development and cellular growth. Impaired Wnt signaling is associated with 
various human diseases including carcinogenesis [27]. The initiation of the Wnt/β-catenin 
signaling requires the formation of a tertiary complex composed of a soluble Wnt ligand, the 
receptor Frizzled (Fz) and low-density lipoprotein receptor-related protein 6 (LRP6) as a co-
receptor. This leads to the stabilization of β-catenin, which translocates into the nucleus and 
induces transcription of downstream genes [28]. An important step in this cascade is the 
aggregation of LRP6 and the formation of a signalosome at the plasma membrane [29]. 
Following LRP6 phosphorylation, the complex is internalized in vesicle and subsequent 
endocytosis is essential to transduce the signal [28, 30, 31]. 
From their screen, Cruciat et al. revealed that (P)RR is important to initiate the canonical Wnt 
signaling pathway [26] (Figure 1). Absence of (P)RR resulted in abnormal frog embryos with 
small heads, shortened tails and hypopigmentation as described in (P)RR mutant zebrafish 
embryos [21, 22] (http://zfin.org). In addition, a loss of anterior-posterior neural patterning 
was also observed. They showed that (P)RR was required for V-ATPase-mediated 
signalosome acidification and subsequent LRP6 phosphorylation [26] (Figure 3). Indeed, 
decreased acidification following inhibition of V-ATPase by RNAi and pharmacological 
treatment, impaired LRP6 phosphorylation and Wnt signaling in two different cell lines, and 
mimicked results obtained after deletion of (P)RR. At the molecular level, (P)RR was 
described to provide a bridge between the Wnt receptor complex and the V-ATPase. 
Interestingly, the extracellular domain of the (P)RR was sufficient to bind Fz8 and LRP6 
(Figure 2) but the transmembrane domain was necessary to transduce the signal. On the 
contrary, both domains were required to bind (directly or indirectly) ATP6V0C and 
ATP6V0D1 (Figure 2). Thus, the cytoplasmic part of the (P)RR which is important for signal 
transduction after (pro)renin binding does not seem to play a role here. Also, it is important to 
stress that prorenin is absent at early stages of development and renin addition did not 
influence the Wnt reporter assay. Altogether, this study was the first to provide an explanation 
for the essential role of (P)RR for normal embryonic development, independently of its ability 
to bind (pro)renin.  
DROSOPHILA 
 
In addition to the canonical Wnt signaling described above, two additional noncanonical 
pathways are also existing and known as Wnt/Ca2+ and the planar cell polarity (PCP) 
pathway. The latter involves Fz receptors and the downstream activation of small GTPases 
inducing expression of their target genes and changes in cytoskeleton dynamics [28]. The 
PCP is a highly conserved pathway essential to orient and polarize cells in the plane of a 
tissue. In Drosophila, PCP is important for the orientation of hairs and bristles of the wing 
among other structures. Two independent genome-wide RNA interference (RNAi) screens in 
Drosophila revealed an important role of the gene CG8444 in the canonical Wnt signaling 
[32] and the PCP pathway [33]. This gene codes for a transmembrane protein which was 
originally named VhaM8-9 due to its sequence homology to ATP6ap2 but whose function 
was not fully characterized [34]. In the two novel studies, to refer to its role as a receptor of 
(pro)renin, it was renamed to dPRR (Drosophila homolog of prorenin receptor) by Buechling 
et al. and to VhaPRR (vacuolar-type H+-ATPase prorenin receptor) by Hermle et al. [35, 36]. 
These studies in Drosophila concordantly described a role of (P)RR in the PCP pathway [35, 
36] (Figures 1 and 3). siRNA against (P)RR resulted in severe PCP defects, characterized by 
abnormal anterior-posterior orientation and hair mispolarization. Interestingly, the phenotype 
could be rescued by injection of the full-length human (P)RR mRNA but not with a N-
terminally truncated form [35, 36]. This suggested an essential role of the extracellular 
domain to transduce the noncanonical Wnt signaling, in a fashion similar to what has been 
described for the canonical signaling [26]. In addition, (P)RR was shown to interact with Fz 
(Figure 2), and the lack of (P)RR impaired targeting of Fz to the plasma membrane and thus 
disrupted its asymmetric localization necessary for normal pupal wings [35, 36]. In contrast, 
components of the canonical signaling (Fz2 receptor and coreceptor arrow) displayed a 
normal localization [36]. Thus, it was suggested that (P)RR, through potential regulation of 
V-ATPase, was important for PCP initiation by trafficking specifically Fz to the plasma 
membrane. To study this functional association, RNAi against 12 V-ATPase subunits were 
tested. Surprisingly, only the deletion of the subunit B mimicked the severe defects observed 
after (P)RR ablation [36]. Thus, the exact mechanism remained obscure and requires further 
analysis. The absence of a renin/prorenin system in Drosophila suggests that this mechanism 
does not involve the ability of (P)RR to bind (pro)renin.  
In an effort to better understand the role of (P)RR within the PCP pathway, the group of M. 
Simons generated mutant flies with clonal deletion of (P)RR in the pupal wing [37]. In 
epithelial cells, an important feature of the PCP signaling is the formation of asymmetric PCP 
domains at apical junctions. To date, six proteins including Fz and Flamingo (Fmi) were 
described to form these structures and are termed PCP core proteins. This study showed that 
clonal elimination of (P)RR led to strong PCP defects consistent with the previous reports 
[35, 36] but it also provided new molecular mechanisms for (P)RR (Figure 1). Indeed, (P)RR 
was shown to co-localize with PCP core proteins during all stages of pupal wing development 
[37]. Absence of (P)RR reduced the presence of PCP proteins such as Fz and Fmi at apical 
junctions of cells (Figure 3). Instead, these proteins were seen to localize in vesicular 
compartments. Previously described to bind Fz, the extracellular domain of (P)RR interacted 
also with Fmi in this model and thus, was important for normal targeting of both proteins 
(Figures 2 and 3). Interestingly, the cleavage site and hence the soluble (P)RR were not 
required for normal PCP signaling as rescue of mutant flies with a construct expressing a non-
cleavable (P)RR restored all aspects of the phenotype. A reciprocal association was also 
revealed with an essential role of Fmi to recruit (P)RR to the PCP domain and for subsequent 
apical trafficking. Altogether, these results suggested that (P)RR possessed all the 
characteristics of a PCP core protein and may be considered as such. It is important to note 
that genetic manipulation of several V-ATPase subunits did not impair PCP defects nor 
asymmetric localization of PCP core proteins. However, one substantial difference with 
mutants for PCP core proteins was that lack of (P)RR significantly affected cell viability. It 
suggested that (P)RR might play an additional role due to its association with the V-ATPase 
[37]. Using elegant experiments based on endocytosis quantification and pH monitoring, they 
showed that (P)RR regulated acidification of specific apical vesicles but did not interfere with 
other vesicle populations. Defective apical vesicles led to a mistrafficking of the 
transmembrane protein E-cadherin which could not transit through the endolysosomal 
pathway and undergo lysosomal degradation. Instead, after normal endocytosis, E-Cadherin 
was recycling back to the apical membrane. Thus it appeared that (P)RR had a specific role 
for recycling apical vesicles in epithelial cells (Figures 1 and 3). A very important discovery 
was also that V-ATPase-mediated acidification of certain compartments did not require 
(P)RR. In contrast, V-ATPase was required for acidification of all vesicles as mutant flies for 
Vha6-2 (ATP6V1A) showed impaired endocytosis and subsequent acidification at the apical 
and basal areas. 
Altogether, this study unrevealed that (P)RR and V-ATPase shared overlapping role in the 
endolysosomal pathway but exhibit distinct functions in the PCP pathway. 
MOUSE 
 
Our early attempts to generate a (P)RR deficient mouse were unsuccessful as no chimeras 
were obtained after implantation of blastocysts containing (P)RR deficient embryonic stem 
cells into foster mothers [17]. This suggested that the complete deletion of (P)RR was lethal 
(Figure 1). Although embryonic lethality could not be ascertained, this was reminiscent of the 
early death observed in mutant zebrafish. Nevertheless, such early lethality in the mouse 
would rule out a function of the (P)RR solely as a component of the RAS. Indeed, mice 
deficient for various RAS components (renin, angiotensinogen…) develop normally [38]. 
Thus, it was suggested that this essential role of (P)RR should involve an additional function 
independently of the RAS. 
To circumvent this early death, conditional deletions of (P)RR in mice using the Cre/Lox 
system were developed (Figure 1). The first tissue-specific deletion of (P)RR in mouse 
confirmed the potential influence of (P)RR on V-ATPase function in particular in the process 
of autophagy (Figure 3). Autophagy is a general term for an essential cellular process 
allowing the cell to degrade organelles and cytosolic proteins. Autophagy plays important 
physiological roles for adaptation to starvation, development, elimination of pathogens and 
cell death. This non-specific process is initiated with the engulfment of a portion of cytoplasm 
within a specific organelle called autophagosome [39, 40]. These engulfed components are 
degraded when this structure further fuses with lysosomes containing pH-dependent 
hydrolases. The V-ATPase plays a fundamental role within this process by generating the 
acidic pH necessary for hydrolase activity.  
Mice with a specific deletion of (P)RR in cardiomyocytes developed abnormal heart 
parameters resulting in heart failure and died within 3 weeks after birth [41]. Histologic 
observations revealed vast fibrotic areas and degenerating cardiomyocytes exhibiting 
perinuclear accumulation of autophagic vacuoles. Similar observations were obtained for 
mice with a conditional deletion of (P)RR in podocytes which developed nephrotic syndrome 
and fulminant kidney failure leading to death within 2-4 weeks after birth [42, 43]. Podocyte 
death was also associated with an accumulation of undigested proteins in autophagic vacuoles 
and enhanced ER stress. In addition, these cells exhibited features of a more global 
dysfunction with altered cytoskeleton, loss of differentiation markers and evidence of 
necrosis. These results were mimicked in vitro in embryonic fibroblasts [41] and podocytes 
[42, 43] after treatment with bafilomycin. In addition, (P)RR ablation in these cells in culture 
induced a downregulation of several subunits of the V0 sector of the V-ATPase and impaired 
acidification [41-43]. Such impairment in autophagy is reminiscent of the phenotype observed 
in yeast lacking a single V0 subunit or proteins involved in the V-ATPase assembly [44, 45].  
Altogether, these studies in the mouse have suggested that the lack of (P)RR may impact on 
V-ATPase assembly, stability or expression. However, the exact mechanism is still unknown 
and further investigations are necessary.  
HUMAN 
Genome-wide association studies with Japanese cohorts have revealed various 
polymorphisms in the (P)RR/ATP6ap2 gene  associated with increased cardiovascular risks in 
humans [6]. Firstly, the 5+169C>T polymorphism was significantly associated to blood 
pressure in Japanese men [46] and more recently also in Caucasian men [47]. Secondly, the 
+1513A>G polymorphism was significantly associated with the risk of lacunar infarction and 
left ventricular hypertrophy in Japanese women [48]. Finally, two additional polymorphisms 
were significantly associated with hypertension in additional populations with vascular 
diseases [49]. However, none of these reports provided evidence of an impact of these 
polymorphisms on (P)RR/ATP6ap2 expression or function. 
In fact, the most interesting clinical aspect has been provided by Ramser et al. in 2005. This 
study identified a unique exonic splice enhancer mutation (c.321C>T) resulting in the deletion 
of the exon 4 (Δe4 isoform) and in a reduction of 50% in the amount of the functional protein 
[50]. This mutation does not lead to cardiovascular abnormalities but results in X-linked 
mental retardation (XLMR) and epilepsy (Figure 1). Interestingly, the authors still linked this 
phenotype to the RAS: indeed, experiments conducted on the lymphocytes of one patient 
bearing the mutation, showed that the Δe4 isoform was unable to activate ERK1/2 in the 
presence of renin. This result suggested that the function as a receptor for renin might be 
involved in neuron physiology [50].  
A recent study found the same mutation in a patient with another X-linked mental disease 
[51]. In addition, the authors described a new mutation c.345C>T associated with X-linked 
Parkinsonism with spasticity (XPDS). This mutation also resulted in exon 4 skipping and 
overexpression of the minor splice Δe4 isoform. In HEK293 cells transfected with siRNA, 
(P)RR ablation impaired autophagy and lysosomal clearance as observed in XPDS brain 
sections. Of note, the most drastic effects were found in the striatum, a region involved in 
Parkinson’s disease, and associated with an accumulation of Tau protein [52]. Interestingly, 
transfection of the Δe4 isoform into (P)RR-depleted HEK293 cells did not significantly 
influence the canonical Wnt signaling pathway as assessed by luciferase reporter assay [51]. 
This study confirmed that (P)RR mutations are associated with various mental diseases but 
the described mechanism differed from the initial study [50]. Even though (pro)renin binding 
activity of (P)RR was not excluded, the defective autophagy strongly argued for a role of 
(P)RR as regulator of V-ATPase activity. This conclusion was in line with the work of 
Contrepas et al. which showed that the truncated (P)RR/ATP6ap2 acted as a dominant 
negative mutant in transfected neuronal cells by affecting the trafficking of the endogenous 
receptor [53]. Because only one copy of (P)RR/ATP6ap2 is present per synaptic vesicle [54], 
it was suggested that intact (P)RR may be important for vesicle trafficking and/or recycling 
and more generally for neurotransmission. In light of the recent findings, we can assume that 
this impaired neurotransmission might be a consequence of abnormal cell homeostasis due to 
impaired autophagy and vesicular acidification. 
CONCLUSIONS AND PERSPECTIVES 
 
From its initial description as a receptor for (pro)renin in 2002, the understanding of (P)RR 
has markedly evolved. It got named ATP6ap2 and an essential role as a modulator of V-
ATPase activity was suggested (Figure 1). Accordingly, several animal models have 
confirmed that (P)RR is important for canonical Wnt and PCP signaling, autophagy and 
vesicular trafficking, all processes in which the V-ATPase is also involved (Figure 2). 
However, the exact mechanism how (P)RR regulates the V-ATPase is still obscure.  
Multivesicular bodies (MVBs) also known as multivesicular endosomes are structures 
sequestering early and late endosomes before lysosomal degradation [14, 55]. MVBs have 
been described to be essential for the transduction of canonical Wnt signaling [56] but also to 
generate exosomes containing Wnt proteins [57]. Several studies reported that V-ATPase 
regulates the function of MVBs [57-59]. Thus, it would be interesting to investigate whether 
(P)RR is important for the generation and maturation of MVBs. 
Another important aspect is that (P)RR and V-ATPase are not always working in concert to 
regulate trafficking and acidification in epithelial cells [37]. Thus, it is essential to decipher in 
which mechanisms (P)RR is important for V-ATPase activity. Also, the role of (P)RR 
described in polarized cells has to be confirm in other cell types. In addition, growing 
evidence suggest that the V0 domain of the V-ATPase orchestrates membrane fusion 
independently of its proton pump activity during synaptic exocytosis, osteoclastogenesis and 
phagocytosis [60-62]. A recent study in yeast has suggested that a specific conformation of 
the V0 subunits is required for proper vacuole fusion [63]. Because membrane fusion is 
important for autophagolysosome formation and vesicle endo/exocytosis, it is tempting to 
speculate that (P)RR might be important not only for acidification, but also for membrane 
fusion. This potential dual function of (P)RR has yet to be proven and certainly requires 
additional studies. 
The exact role and regulation of the s(P)RR is also still unclear. It was described that s(P)RR 
can be secreted by cells into the blood stream [9] and this aspect initiated the development 
of enzyme-linked immunosorbent assays to detect and quantify s(P)RR in various biological 
fluids [4, 64]. From developmental studies, it was shown that s(P)RR can bind to Fz and 
LRP6 in in vitro assay but could not rescue Wnt signaling after (P)RR depletion [26]. Also, 
s(P)RR was described to be endocytosed together with Fmi in epithelial cells but without any 
relevance for PCP signaling or cell viability [37]. Accordingly, the meaning of such 
interactions in vivo is totally unknown.  
Finally, as a new member of the local RAS, targeting the extracellular part to inhibit the 
(pro)renin/(P)RR binding was very tempting until few years ago. However, the lack of in vivo 
evidence that this interaction triggers signaling pathways independently of the generation of 
Ang II, the ongoing controversy on the efficiency of the putative (P)RR blocker (HRP) and 
last but not least, the essential role of (P)RR in cell physiology, will probably put a brake on 
this idea. If not, one should carefully evaluate potential blockers to exclude any adverse 
effects due to impairment of V-ATPase function. For instance, a recent study showed that in 
vitro, HRP could act as a partial agonist and stimulate V-ATPase activity in a (P)RR-
dependent manner [65]. Further knowledge about the exact contribution of the extracellular 
part to the V-ATPase activity will probably precede any drug design and blocking strategy. 
After 10 years of intensive research, the role of (P)RR as a regulator of V-ATPase function is 
now well described but there are still a lot of questions about its role in cellular and 
physiological functions. 
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FIGURE LEGENDS 
 
Figure 1: Timeline of (P)RR characterization. The timeline summarizes the different 
studies describing an association between (P)RR and V-ATPase. For references see text. PCP, 
planar cell polarity; (P)RR, (pro)renin receptor; XLMR, X-linked associated mental 
retardation; XPDS, X-linked Parkinsonism with spasticity. 
 
Figure 2: Structure and potential binding partners of (P)RR. Proteins from various Wnt  
signaling pathways and from the V-ATPase complex have been shown to interact (directly or 
indirectly) with (P)RR. For references see text. Fmi, Flamingo; Fz, Frizzled; LRP6, low-
density lipoprotein receptor-related protein 6; PCP, planar cell polarity; (P)RR, (pro)renin 
receptor; RAS, renin-angiotensin system; V-ATPase, vacuolar H+ ATPase. 
 
Figure 3: Functions of (P)RR. In Xenopus, (P)RR was shown to be important for canonical 
Wnt signling. In mice, a role of (P)RR in the regulation of autophagy was described. In 
Drosophila, (P)RR was essential for PCP core protein trafficking and for 
endocytosis/recycling of apical proteins. For references see text. E-Cad, E-cadherin; ER, 
endoplasmic reticulum; Fmi, Flamingo; Fz, Frizzled; LRP6, low-density lipoprotein receptor-
related protein 6; PCP, planar cell polarity; (P)RR, (pro)renin receptor; V-ATPase, vacuolar 
H+ ATPase. 
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